Coverage
-
June 20, 2016
A New Jersey federal judge on Monday threw out a proposed shareholder class action claiming Aerie Pharmaceuticals Inc. misled investors about the potential of a new glaucoma treatment, saying the investors had taken the company's statements out of context.
3 other articles on this case.
View all »